News
August 12, 2022

Regenstrief Institute appoints Nist interim CIO

Robert Nist

The Regenstrief Institute has appointed Robert L. Nist as interim chief information officer (CIO), commencing August 17. He is a highly experienced executive at the intersection of technology, the pharmaceutical industry and healthcare.

Nist began working as an independent consultant after a nearly four-decade career with Eli Lilly and Company and Rockwell Automation. He spent the majority of his career at Lilly, where he held numerous positions including vice president and divisional CIO for medicines development, manufacturing, quality and connected care. Prior to that, he served as vice president and CIO for diabetes manufacturing and quality at Elanco Animal Health. At Rockwell he served as vice president for technology management.

“I am pleased that this highly regarded professional, who has a deep understanding of how to use technology to promote human health, has agreed to join us on an interim basis to help lead our innovative organization,” said Regenstrief Interim President and Chief Executive Officer Susan Hickman, PhD. “His business acumen, healthcare expertise and technology skills are a strong fit for our organization. We look forward to working with Bob and benefiting from his considerable strategic, tech savvy leadership.”

Nist earned bachelor of science degrees in chemistry and chemical engineering from Purdue University, where he also earned a master of science degree in computer and information science. He is a current member of Purdue’s Engineering Ethics and Compliance Advisory Group and Anderson University’s Engineering Advisory Group.

Related News

Kurt Kroenke, MD

The Impact of Patient Race, Patient Socioeconomic Status, and Cognitive Load of Physician Residents and Fellows on Chronic Pain Care Decisions

Published in the Journal of Pain. Here is a link to the article.  Regenstrief Institute authors:  Kurt Kroenke, PhD 

Shaun Grannis and Brian Dixon

Latest booster reduces adults’ risk of moderate or severe COVID by more than half

The most recent COVID-19 booster shot reduces adults’ risk of moderate or severe COVID by more than half, according

April Savoy, PhD

Closing the referral loop: perspectives and experiences of primary care and specialist physicians

INDIANAPOLIS – Every year, millions of referrals are made by primary care physicians in the U.S. for patients needing